Is CAR T-Cell Therapy the Future of Cancer Treatment?

Dr. David Maloney, an associate professor of medicine at the University of Washington and medical oncologist at Seattle Cancer Care Alliance, discusses his excitement over CAR (chimeric antigen receptor) T-cell therapy. As a leader in this research, Dr. Maloney describes the wave of research efforts behind this adoptive T-cell therapy using the patients own immune cells to fight back against the cancer, including blood cancers like lymphoma and chronic lymphocytic leukemia (CLL). Dr. Maloney provides insight on the process of collecting T-cells and what the future holds for CAR T-cell therapy and its potential extension to not only blood cancers, but perhaps broadening its application in lymphoma, lung, ovarian and other solid tumors. View Dr. Maloney's profile: http://www.seattlecca.org/doctor/david-g-maloney.cfm View information about Dr. Maloney's T-cell trial: http://www.seattlecca.org/clinical-trials/lymphoma-NCT01865617.cfm Learn more about CAR T-cell therapy: http://www.seattlecca.org/diseases/immunotherapy-t-cell-therapies.cfm View a photo of a scan that shows the results of this promising therapy: https://twitter.com/HutchinsonCtr/status/453205116829454336/photo/1